e-learning
resources
Amsterdam 2011
Tuesday, 27.09.2011
Pathobiology of experimental pulmonary hypertension
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Expression and role of the nerve growth factor NGF in pulmonary hypertension
V. Freund-Michel, M. Dubois, D. Dahan, A. Courtois, R. Marthan, J. P. Savineau, B. Muller (Bordeaux, France)
Source:
Annual Congress 2011 - Pathobiology of experimental pulmonary hypertension
Session:
Pathobiology of experimental pulmonary hypertension
Session type:
Oral Presentation
Number:
3433
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
V. Freund-Michel, M. Dubois, D. Dahan, A. Courtois, R. Marthan, J. P. Savineau, B. Muller (Bordeaux, France). Expression and role of the nerve growth factor NGF in pulmonary hypertension. Eur Respir J 2011; 38: Suppl. 55, 3433
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The definition of pulmonary hypertension: history, practical implications and current controversies
Should we screen for hereditary pulmonary hypertension?
Patient with ankylosing spondylitis and pulmonary hypertension
Related content which might interest you:
Potential role of the nerve growth factor NGF in pulmonary arterial hypertension
Source: Annual Congress 2009 - Pathobiology of pulmonary vascular diseases
Year: 2009
Nerve growth factor expression and function in pulmonary arterial hypertension
Source: Annual Congress 2010 - Pathobiology of pulmonary hypertension
Year: 2010
Role of Connexin 43 increased expression in pulmonary arterial hyperreactivityinduced by the nerve growth factor NGF
Source: Virtual Congress 2021 – Pathogenesis and pathophysiology of pulmonary hypertension
Year: 2021
Expression and functional analysis of the transforming growth factor (TGF)-β superfamily in pulmonary arterial hypertension: role of PAI-1 in disease progression
Source: Eur Respir J 2007; 30: Suppl. 51, 53s
Year: 2007
Bioavailability of vascular endothelial growth factor (VEGF)? A role in pulmonary fibrosis?
Source: Annual Congress 2012 - Fibrogenesis between epithelial injury and fibroblast proliferation
Year: 2012
A role for vascular endothelial growth factor (VEGF) in fibrosis?
Source: Annual Congress 2009 - From emphysema to fibrosis: mechanisms of cellular remodelling in the diseased lung
Year: 2009
Nerve growth factor levels and localisation in human asthmatic bronchi
Source: Eur Respir J 2002; 20: 1110-1116
Year: 2002
Dual mechanism of platelet-derived growth factor (PDGF)-receptor: Contribution of vascular response to the pathogenesis of pulmonary hypertension (PH)
Source: International Congress 2015 – Pulmonary hypertension: novel insights into the biology of the disease
Year: 2015
Diaphragmatic angiogenic growth factor mRNA responses to increased ventilation caused by hypoxia and hypercapnia
Source: Eur Respir J 2001; 17: 681-687
Year: 2001
Serum levels of insulin-like growth factor binding protein-3 and vascular endothelial growth factor in obstructivesleep apnea patients. Effect of CPAP treatment
Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I
Year: 2012
Down regulation of human insulin-like growth factor in lung tissue of patients with idiopathic pulmonary fibrosis
Source: Eur Respir J 2007; 30: Suppl. 51, 574s
Year: 2007
The expression of brain-derived neurotrophic factor in hippcocampal and serum of chronic obstructive pulmonary disease model rats
Source: Annual Congress 2011 - COPD mechanisms
Year: 2011
Interdependence of endothelin-1 and transforming growth factor-β
1
on Wnt3a expression in idiopathic pulmonary fibrosis
Source: Annual Congress 2012 - Diffuse parenchymal lung disease pathogenesis, biomarkers, therapy and new entities
Year: 2012
The clininical value of vascular endothelial growth factor (VEGF) in the development of lung sarcoidosis.
Source: International Congress 2018 – Sarcoidosis: from basic research to patient outcomes
Year: 2018
Expression of vascular endothelial growth factor (VEGF) and epidermal growth factor receptor (EGFR) as a prognostic factor of survival in patients with lung adenocarcinoma
Source: Annual Congress 2008 - Management, quality aspects and prognosis in thoracic oncology
Year: 2008
Vascular endothelial growth factor levels in active pulmonary tuberculosis
Source: Eur Respir J 2002; 20: Suppl. 38, 610s
Year: 2002
The transforming growth factor-β/Smad2,3 signalling axis is impaired in experimental pulmonary hypertension
Source: Eur Respir J 2007; 29: 1094-1104
Year: 2007
Transforming growth factor beta induces Beclin-1 in pulmonary arterial endothelial cells
Source: Virtual Congress 2020 – Chronic thromboembolic pulmonary hypertension
Year: 2020
Human lung fibroblasts secrete nerve growth factor: effect of inflammatory cytokines and glucocorticoids
Source: Eur Respir J 2001; 18: 115-121
Year: 2001
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept